You are here:Home-Chemical Inhibitors & Agonists-Apoptosis-Apoptosis Inducer-CCI-007
CCI-007

Chemical Structure : CCI-007

CAS No.: 939228-52-1

CCI-007 (CCI007; CCI 007)

Catalog No.: PC-36025Not For Human Use, Lab Use Only.

CCI-007 (CCI 007) is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485.

Packing Price Stock Quantity
10 mg $198 In stock
25 mg $298 In stock
100 mg $698 In stock
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

CCI-007 (CCI 007) is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485.
CCI-007 induced a rapid caspase-dependent apoptosis with mitochondrial depolarization within 24h treatment.
CCI-007 altered the characteristic MLL-r gene expression signature in sensitive cells with downregulation of the expression of HOXA9, MEIS1, CMYC and BCL2, important drivers in MLL-r leukemia.

Physicochemical Properties

M.Wt 336.362
Formula C15H16N2O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Ethyl-2-(4-((2-imino-4-oxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)acetate

References

1. Somers K, et al. Oncotarget. 2016 Jul 19;7(29):46067-46087.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: